Almirall opens Shanghai hub to power dermatology innovation and China partnerships
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems
Germany will be the first launch market
Their findings, published in the journal Nature, reveal that the spines’ unique porous internal structure allows them to convert water movement into measurable electrical signals
NCFB is a chronic lung condition where damaged airways cause persistent coughing and mucus production
This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
The move follows encouraging Phase I data and a series of regulatory wins from the U.S. Food and Drug Administration
Investment marks continued progress against AbbVie's $100 billion commitment to U.S. R&D and capital investments, including manufacturing, over the next decade
Subscribe To Our Newsletter & Stay Updated